Role of antioxidants in the prevention of cancer;Papel de los antioxidantes en la prevención del cáncer

Revista Espanola de Nutricion Humana y Dietetica

Volumn 16, Issue 1, 2012, Pages 16-24

  Llacuna, Laura ^a   Mach, Nuria ^a,b  

^a UNIVERSITAT OBERTA DE CATALUNYA   (Spain)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antioxidant; Cancer; Free radicals; Glutathione; Lysozyme

Indexed keywords

GLUTATHIONE; LYSOZYME;

ANTIOXIDANT ACTIVITY; CANCER CELL; CANCER PREVENTION; DIET; HUMAN; KNOWLEDGE; OXIDATIVE STRESS; REVIEW;

EID: 84856957481     PISSN: 21731292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2173-1292(12)70067-4     Document Type: Review

References (90)

1. Adachi M., Zhang Y., Zhao X., Minami T., Kawamura R., Hinoda Y., et al. Clin Cancer Res 2004, 10:3853-3862.
2. Anand P., Kunnumakkara A.B., Kunnumakara A.B., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008, 25:2097-2116.
3. Kinzler K.W., Vogelstein B. The genetic basis of human cancer 2002, McGraw-Hill, New York, p5. 2.a ed.
4. Irigaray P., Newby J.A., Clapp R., et al. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007, 61:640-658.
5. Matill H.A., Antioxidants Annu Rev Biochem 1947, 16:177-192.
6. Roche E., Romero D. Estrés oxidativo y degradación de proteínas. Med Clin (Barc) 1994, 103:189-196.
7. Cotran RS, et al. Patología estructural y funcional. 5.a ed. Mc-Graw-Hill/Interamericana.
8. Martins M.A., et al. Interaction between inflammation and systemic haematologic effect of PAF-acether in the rat. L Pharmacol 1989, 36:333-360.
9. Jiménez S. Antioxidantes y RL en el tabaquismo 2003, Solo-Mujeres, Buenos Aires.
10. Knight J. Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci. 28:331-46.
11. Coulter I., Hardy M., Morton S., Hilton L., Tu W., Valentine D., et al. Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer. J Gen Intern Med 2007, 21:735-744.
12. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB. J Biol Chem. 1999, 274:27891-27897.
13. Perez-Galan P., Roue G., Villamar N., Campo E., Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantlecell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006, 107:257-264.
14. Atalla S., Toledo-Pereya L.H., McKenzie G.H., Cederna J.P. Influence of oxygen-derived free scavengers. Transplantation 1985, 40:584-590.
15. McWen BS. Protective and damaging effects of stress mediators. N Engl J Med.
16. De Ross A.J., et al. Cancer incident among Glyphosate-Exposed Pesticida Applicators in the Agricultural Health Study. Environ Health Perspect 2005, 113:49-54.
17. Shimosawa T. [Increasing oxidative stress in aging]. Nippon Rinsho 2005, 63:994-999.
18. Southern P.A., Powis G. Medicine. II. Involvement in human disease. Mayo Clin Proc 1994, 63:390-404.
19. Altamar J. Herbicidas y Malf. Congén. en el Meta, Colombia. Actividad Patogénica de los RL. Orinoquia, Villavicencio, Colombia, 2002; 6: 9-35.
20. Guyton A.C., et al. Tratado de Fisiología 1997, Mc-Graw-Hill/Interamericana, México. 9. aed.
21. Villa Pérez M. RL de O2 y la enfermedad. Conferencia en la VI Reunión del Grupo Español de RL. Cádiz, 26-28 de Junio de 2002.
22. De Ross A.J., et al. Cancer incidente among Glyphosate-Exposed Pesticida Applicators in the Agricultural Health Study. Environ Health Perspect 2005, 113:49-54.
23. Hallivell B., Current review. Free reactive oxygen species human disease, a critical evaluation with special reference to aterosclerosis. B Exp Path 1995, 70:737-757.
24. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005, 39:359-407.
25. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., et al. Proc Natl Acad Sci U S A. 2005, 102:719-724.
26. Szatrowski T.P., Nathan C.F. Cancer Res 1991, 51:794-798.
27. Schumacker P. Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 2006, 10:175-176.
28. 2 availability on human cancer. Nat Rev Cancer 2008, 8:967-975.
29. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors i n tumorogenesis. Cell Death Differ 2008, 15:678-685.
30. Denko N.C. Hypoxia, HIF1 and glucosa metabolism in the solid tumor. Nat Rev Cancer 2008, 8:705-713.
31. Guzy R.D., Hoyos B., Robin E., et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005, 1:401-408.
32. Lluis J.M., Buricchi F., Chiarugi P., Morales A., Fernandez-Checa J.C. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-kappa B via c-SRC and oxidant-dependent cell death. Cancer Res 2007, 67:7368-7377.
33. Han D., Hanawa N., Saberi B., Kaplowitz N. Mechanisms of liver injury Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol 2006, 291:G1-G7.
34. Altamar J. The role of lysozime on etiopathogenesis and treatment on juvenile laryngeal papillomatosis. Otolaryngol Torino 1998, 44:17-20.
35. Bjelakovic G., Gluud L.L., Nikolova D., Bjelakovic M., Nagorni A., Gluud C. Antioxidant supplements for liver diseases. Cochrane Database Syst Rev 2011, (3). CD007749.
36. Cranganu A., Camporeale J. Nutrition aspects of lung cancer. Nutr Clin Pract 2009, 24:688-700.
37. Persson C., Sasazuki S., Inoue M., Kurahashi N., Iwasaki M., Miura T., et al. Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study. Carcinogenesis 2008, 29:1042-1048.
38. Charniot J.C., Vignat N., Albertini J.P., Bogdanova V., Zerhouni K., Monsuez J.J., et al. Oxidative stress in patients with acute heart failure. Rejuvenation Res 2008, 11:393-398.
39. Eledrisi MS, McKinney K, Shanti MS. Vitamin A toxicity [citado 2 Sep 2009]. Disponible en: http://emedicine.medscape.com/article/126104-overview.
40. Litwack G., Vitamin A. Vitamins and hormones 2007, Elsevier.
41. Wilson L.G. The clinical definition of scurvy and the discovery of vitamin C. J Hist Med 1975, 40-60.
42. Challem J.J., Taylor E.W. Retroviruses, ascorbate, and mutations, in the evolution of Homo sapiens. Free Radical Biology and Medicine 1998, 25:130-132.
43. Bánhegyi G., Braun L., Csala M., Puskás F., Mandl J. Ascorbate metabolism and its regulation in animals. Free Radical Biology and Medicine 1997, 23:793-803.
44. Villamor E., Koulinska I.N., Aboud S., Murrin C., Bosch R.J., Manji K.P., et al. Effect of vitamin supplements on HIV shedding in breast milk. Am J Clin Nutr 2010, 92:881-886.
45. Huang J., Agus D.B., Winfree C.J., Kiss S., Mack W.J., McTaggart R.A., et al. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci 2001, 98:11720-11724.
46. Ichim T.E., Minev B., Braciak T., Luna B., Hunninghake R., Mikirova N.A., et al. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?. J Transl Med 2011, 9:25.
47. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium and Carotenoids 2000, Institute of Medicine, Food and Nutrition board, National Academy Press, Washington.
48. Rosenberg H., Feldzamen A.N. The book of vitamin therapy 1974, Berkley, New York.
49. Balendiran G.K., Dabur R., Fraser D. The role of glutathione in cancer. Cell Biochem Funct 2004, 22:343-352.
50. Pompella A., Visvikis A., Paolicchi A., De Tata V., Casini A.F. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003, 66:1499-1503.
51. Bounous G., Gold P. The biological activity of undenatured dietary whey proteins: role of glutathione. Clin Invest Med 1991, 14:296-309.
52. Meister A., Yaniguchi N., Higashi T., Sakamoto Y. Glutathione centennial 1989, Academic Press, San Diego, 3-21.
53. Griffith O., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine. J Biol Chem 1979, 254:7558-7560.
54. Meister A. Glutathione metabolism. Methods Enzymol Rev 1995, 251:3-7.
55. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J Nutr 2004, 134:489-492.
56. Cooper A. Biochemistry of sulfur-containing amino acids. Annu Rev Biochem 1983, 52:187-222.
57. Wahllander A., Soboll A., Sies H. Hepatic mitochondrial and cytosolic glutathione content and the subcellular distribution of GSH-S- transferases. FEBS Lett 1975, 97:138-140.
58. García-Ruiz C., Morales A., Colell A., Ballesta A., Rodés J., Kaplowitz N., et al. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994, 94:193-201.
59. Sa G., Das T., Moon C., et al. GD3, an overexpressed tumor-derived ganglioside, mediates apoptosis of activated but not resting T cells. Cancer Res 2009, 69:3095-3104.
60. Witschi A., Reddy S., Stofer B., Lauterburg B.H. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992, 43:667-669.
61. S-Adenosyl-L-methionine: its role in the treatment of liver disorders. Am J Clin Nutr 2002, 76:S1183-S1187.
62. Vendemiale G., Altomare E., Trizio T., Le Grazie C., Di Padova C., Salerno M.T., et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol 1989, 24:407-415.
63. Loguercio C., Nardi G., Argenzio F., Aurilio C., Petrone E., Grella A., et al. Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease. Alcohol Alcohol 1994, 29:597-604.
64. Gross C.L., Innace J.K., Hovatter R.C., Meier H.L., Smith W.J. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol 1993, 9:259-267.
65. Moreno Y.F., Sgarbieri V.C., Da Silva M.N., Toro A.A., Vilela M.M. Features of whey protein concentrate supplementation in children with rapidly progressive HIV infection. J Trop Pediatr 2006, 52:34-38.
66. Grey V., Mohammed S.R., Smountas A.A., Bahlool R., Lands L.C. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003, 2:195-198.
67. Micke P., Beeh K.M., Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIVinfected patients. Eur J Nutr 2002, 41:12-18.
68. Bounous G., Baruchel S., Falutz J., Gold P. Whey proteins as a food supplement in HIV-seropositive individuals. Clin Invest Med 1993, 16:204-209.
69. Shay K.P., Moreau R.F., Smith E.J., Smith A.R., Hagen T.M. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009, 1790:1149-1160.
70. Busse E., Zimmer G., Schopohl B., Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 1992, 42:829-831.
71. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M., Menendez-Pelaez A., Chen L.D., et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995, 26:497-502.
72. Nencini C., Giorgi G., Micheli L. Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine 2007, 14:129-135.
73. Valenzuela A., Aspillaga M., Vial S., Guerra R. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med 1989, 55:420-422.
74. Immunocal Powder Sachets patient advice including side effects.
75. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A 1997, 94:1967-1972.
76. Han Y.H., Park W.H. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione. Oncol Rep 2009, 22:385-391.
77. Chow H.H., Hakim I.A. Modulation of human glutathione s-transferases by polyphenone intervention. Cancer Epidemiol Biomarkers Prev 2007, 16:1662-1666.
78. Balendiran G.K., Dabur R., Fraser D. The role of glutathione in cancer. Cell Biochem Funct 2004, 22:343-352.
79. Jomova K., Jenisova Z., Feszterova M., Baros S., Liska J., Hudecova D., et al. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol 2011, 31:95-107.
80. Ambrozova G., Pekarova M., Lojek A. The effect of lipid peroxidation products on reactive oxygen species formation and nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 macrophages. Toxicol In Vitro 2011, 25:145-152.
81. Rammal H., Bouayed J., Younos C., Soulimani R. Evidence that oxidative stress is linked to anxiety-related behaviour in mice. Brain Behav Immun 2008, 22:1156-1159.
82. Giovannucci E., Ascherio A., Rimm E.B., Stampfer M.J., Colditz G.A., Willett W.C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995, 87:1767-1776.
83. Giovannucci E., Willett W.C., Stampfer M.J., Liu Y., Rimm E.B. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002, 94:391-396.
84. Woodside J., McCall D., McGartland C., Young I. Micronutrients: dietary intake v. supplement use. Proc Nutr Soc 2005, 64:543-553.
85. Cao G., Prior R. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998, 44(6 Pt 1):1309-1315.
86. Marshall K. Therapeutic applications of whey protein. Altern Med Rev 2004, 9:136-156.
87. Pocernich C.B., Bader Lange M.L., Sultana R. Butterfield DA Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr Alzheimer Res 2011, 8:452-469.
88. Lee K.J., Choi C.Y., Chung Y.C., Kim Y.S., Ryu S.Y., Roh S.H., et al. Protective effect of saponins derived from roots of Platycodon grandiflorum on tert-butyl hydroperoxide-induced oxidative hepatotoxicity. Toxicol Lett 2004, 147:271-282.
89. Banni M., Chouchene L., Said K., Kerkeni A., Messaoudi I. Mechanisms underlying the protective effect of zinc and selenium against cadmium-induced oxidative stress in zebrafish Danio rerio. Biometals 2011.
90. Kim J.H., Kim B.W., Kwon H.J., Nam S.W. Curative effect of selenium against indomethacin-induced gastric ulcers in rats. J Microbiol Biotechnol 2011, 21:400-404.